Direct access hybrid transatrial implantation of a Sapien 3 valve inside a bioprosthetic mitral valve with concomitant tricuspid valve replacement and cryoablation
Sophia L. Alexis, Gilbert H. L. Tang, Dimosthenis Pandis, David H. Adams, Ahmed El-Eshmawi
We present the case of a 64-year-old high-risk male with a history of mitral valve (MV) endocarditis post-MV replacement (MVR) in 2005, complicated by MV prosthesis dehiscence due to recurrent endocarditis that required MV re-replacement one year later. Additional co-morbidities include atrial flutter, gastrointestinal bleeding, anemia, chronic kidney disease, and metastatic pancreatic islet cell tumor. In 2018, he represented with class IV congestive heart failure despite maximal medical therapy. An echocardiogram showed severe tricuspid regurgitation (TR), a significantly dilated and dysfunctional right ventricle (RV), and structural MV prosthesis degeneration with severe mitral regurgitation (MR). He was subsequently transferred to our reference center for definitive management.
Share
Publications
-
Independent practice should require thoracic board certification
David H. Adams, MD, Dimosthenis Pandis, MD, Shaf Keshavjee, MD -
Propensity-Matched Comparison of the Ross Procedure and Prosthetic Aortic Valve Replacement in Adults
Ismail El-Hamamsy, MD, PhD, Nana Toyoda, MD, PhD, Shinobu Itagaki, MD, MSc, Paul Stelzer, MD, Robin Varghese, MD, Elbert E. Williams, MD, Natalia Egorova, PhD, David H. Adams, MD -
Aortic Arch Replacement: How I Teach It
Amine Mazine, Nitish K Dhingra, Michael W A Chu, Ismail El-Hamamsy, Mark D Peterson -
Mitral Annular Disjunction: A Contrary View
Dimosthenis Pandis, MD, MSc, Anelechi C. Anyanwu, MD, FRCS, David H. Adams, MD, FACC